Daniel specialises in advising and representing national and international clients in the life sciences sector. His focus is, among others, on all areas of pharmaceutical law, medical device law, pharmaceutical-advertising law, unfair competition law, and trademark law.

 

For more than 10 years, he has been coordinating and supervising disputes concerning competition law and trademark law for his clients and has, besides his specific focus on litigation, also longstanding experience in advising clients on regulatory and compliance matters, particularly, in the aforementioned areas of law. In context with managing litigation and advising his clients, Daniel is characterised by a strong client focus and his ability to find appropriate and efficient solutions to legal problems.

Afficher le CV complet Masquer le CV complet

Actualités et publications récentes

Brevets et innovation

Federal Government White Paper on the Legalisation of Cannabis Products - Details and Questions under European Law

8 novembre 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Sciences de la vie et Santé

TAMG – the new Veterinary Medicinal Products Act

14 septembre 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Responsabilité du fait des produits et de la sécurité des produits

Judgement of the Administrative Court of Cologne: Classification of CBD drops as medicinal products subject to authorization

14 septembre 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus
Responsabilité du fait des produits et de la sécurité des produits

Standstill in the approval process for CBD products as novel foods

14 septembre 2022
Briefing

par Dr. Daniel Tietjen

Cliquer ici pour en savoir plus

Autres avocats qui pourraient vous intéresser